07:26 AM EDT, 05/26/2025 (MT Newswires) -- Cosciens Biopharma ( CSCI ) on Monday said it received a letter from Goodwood, which owns 8.2% of the company, regarding six director nominations for its upcoming shareholder meeting on June 26.

According to a May 23 Goodwood statement, the nominees include Kenneth d'Entremont, Medexus Pharmaceuticals (MDP.TO) chief executive officer, and Anthony Giovinazzo, former chief executive of NASDAQ-listed Cynapsus Therapeutics.

"We respectfully acknowledge receipt of the statement regarding the intentions from Goodwood and are carefully reviewing its contents," said Cosciens Chair Ronnie Miller. "With this in hand, the Board will evaluate and determine its path forward and remains fully committed to acting in the best interests of COSCIENS and our shareholders."